Impact of Vitrification and Blastocyst Transfer on Neonatal Weight – RBMO
Reproductive BioMedicine Online shared a post on LinkedIn about a paper by Ming Li et al. published in RBMO:
“This cohort study investigates whether transferring blastocyst-stage embryos combined with vitrification increases risks of adverse neonatal outcomes, specifically elevated birthweight and rates of large for gestational age (LGA) or macrosomia.
With a sizeable sample of 42,000 singleton live births, the study shows that both blastocyst-stage and vitrified-warmed (frozen) embryo transfers were individually associated with higher birthweight z-scores and increased risks of LGA and macrosomia. The highest risks were observed when both factors were combined (Vitri-blastocyst group).
While VBT has become the predominant strategy in clinical practice to improve live birth rates, these results highlight that FCT should not be prematurely discontinued without medical justification, and VBT should be individualized with careful consideration of infant safety. Although embryo transfer strategies are essential for optimizing pregnancy rates and cycle flexibility, balancing these benefits with potential perinatal risks and personalized care protocols is warranted.
RBMO subscribers can read the full paper from our in-press articles section now.”
Title: The synergistic effect of transfer of blastocyst and embryo vitrification on birthweight: a retrospective cohort study
Authors: Ming Li, Qingqing Tao, Zhengyang Zhao, Jin Huang, Ying Lian, Ping Liu, Qin Li, Rong Li, Jie Qia
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 9, 2025, 13:18Differentiating Diagnostic and Prognostic Embryo Testing – Fertility and Sterility
-
Dec 9, 2025, 13:13Laura Melado Vidales: New Insights on LH Levels in Frozen Embryo Transfer Cycles
-
Dec 9, 2025, 13:09Bonnie Feldman: LJI Scientists Receive WHAM Awards to Advance Sex-Specific Research in Autoimmunity and Women’s Health
-
Dec 8, 2025, 06:17New E-Learning Module on Maternal Vaccinations Launched – RCOG
-
Dec 7, 2025, 18:25Thyroid Autoimmunity’s Impact on ART Outcomes Explored – CEOG
-
Dec 7, 2025, 18:23Join Us at the European Parliament on Fertility Crisis – Fertility Europe
-
Dec 7, 2025, 18:20ANDDE Joined The CNPGOGMA – New Era in Gynecology Collaboration – ANDDE
-
Dec 7, 2025, 18:17Gregory Piazza: New Perspectives on Antithrombotic Use During Pregnancy
-
Dec 7, 2025, 18:14New Insights Into Reproductive Health Using AI Technology – CEOG